Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
antibiotics
Pharma
GSK snags FDA approval for new UTI treatment Blujepa
The company's Blujepa was designed to fight the common condition with a lower potential for antimicrobial resistance.
Zoey Becker
Mar 25, 2025 2:20pm
Paratek buys Optinose, rhinosinusitis spray Xhance for up to $330M
Mar 20, 2025 11:23am
AbbVie scores FDA nod for Pfizer-partnered antibiotic Emblaveo
Feb 10, 2025 8:09am
Iterum nabs FDA approval for oral UTI drug after prior rejection
Oct 25, 2024 2:52pm
With Sandoz contract expiring, GSK will close plant in UK
Sep 9, 2024 11:53am
Daewoong Bio banned from China drug procurement program
Jul 19, 2024 10:21am
